
Liso-Cel CAR-T cell therapy approved for relapsed/refractory follicular lymphoma in the EU and UK
In recent weeks there have been a number of announcements regarding an alternative treatment option now being available for adults with relapsed/ refractory indolent follicular lymphoma (FL) across the EU and transformed follicular lymphoma within the UK.